Fusaroli M.; Raschi E.; Gatti M.; De Ponti F.; Poluzzi E., Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System, «FRONTIERS IN PHARMACOLOGY», 2021, 12, Article number: 740707, pp. 1 - 11 [articolo]Open Access
Fusaroli M.; Raschi E.; Contin M.; Sambati L.; Menchetti M.; Fioritti A.; Poluzzi E., Impulsive conditions in Parkinson's disease: A pharmacosurveillance-supported list, «PARKINSONISM & RELATED DISORDERS», 2021, 90, pp. 79 - 83 [articolo]
Aiello V.; Fusaroli M.; Raschi E.; Palazzini M.; Hu L.; Barbuto S.; Poluzzi E.; Capelli I., Pulmonary Embolism in a Patient With ADPKD Treated With Tolvaptan: From the Clinical Experience to the Analysis of the Food and Drug Administration Adverse Event Reporting System Registry, «KIDNEY INTERNATIONAL REPORTS», 2021, 6, pp. 2472-2477 - 2477 [articolo]Open Access
Gatti M.; Fusaroli M.; Raschi E.; Moretti U.; Poluzzi E.; De Ponti F., Serious adverse events with tedizolid and linezolid: pharmacovigilance insights through the FDA adverse event reporting system, «EXPERT OPINION ON DRUG SAFETY», 2021, 20, pp. 1421 - 1431 [articolo]
Gatti M.; Fusaroli M.; Caraceni P.; Poluzzi E.; De Ponti F.; Raschi E., Serious adverse events with tocilizumab: Pharmacovigilance as an aid to prioritize monitoring in COVID-19, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2021, 87, pp. 1533 - 1540 [articolo]
Raschi, Emanuel; Fusaroli, Michele; Ardizzoni, Andrea; Poluzzi, Elisabetta; De Ponti, Fabrizio, Thromboembolic Events with Cyclin-Dependent Kinase 4/6 Inhibitors in the FDA Adverse Event Reporting System, «CANCERS», 2021, 13, Article number: 1758, pp. 1 - 12 [articolo]Open Access
Raschi E.; Fusaroli M.; Diemberger I.; Poluzzi E., Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance, «DRUG SAFETY», 2020, 43, pp. 1191 - 1194 [articolo]
Iommi M.; Rosa S.; Fusaroli M.; Rucci P.; Fantini M.P.; Poluzzi E., Modified-Chronic Disease Score (M-CDS): Predicting the individual risk of death using drug prescriptions, «PLOS ONE», 2020, 15, Article number: e0240899, pp. 1 - 13 [articolo]Open Access
